Rocklatan™ (netarsudil and latanoprost) – New drug approval
March 12, 2019 - Aerie Pharmaceuticals announced the FDA approval of Rocklatan (netarsudil and latanoprost) 0.02%/0.005% ophthalmic solution, for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension.
Top